| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/03/2001 | US6254872 Protective immune response against infections |
| 07/03/2001 | US6254869 Genetic engineering, vaccines and immunoglobulins |
| 07/03/2001 | US6254868 Monoclonal antibodies |
| 07/03/2001 | US6254867 Human monoclonal antibodies to the hepatitis B surface antigen |
| 07/03/2001 | CA2185568C Chlamydia vaccines and process |
| 07/03/2001 | CA2116348C Sirs vaccine and diagnosis method |
| 07/03/2001 | CA2078773C Gp75 as a tumor vaccine for melanoma |
| 07/03/2001 | CA2012993C Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/28/2001 | WO2001046696A2 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | WO2001046422A1 Novel cytokine zcyto18 |
| 06/28/2001 | WO2001046420A2 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 06/28/2001 | WO2001046418A1 Human slit polypeptide zslit3 |
| 06/28/2001 | WO2001046408A2 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046390A2 Method of inactivating microorganisms |
| 06/28/2001 | WO2001046389A2 Immature autologous clinical grade dendritic cells intended for vaccination of cancer patients |
| 06/28/2001 | WO2001046383A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 06/28/2001 | WO2001046261A1 Method for treating inflammation |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046254A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046228A2 Nucleic acid vaccination |
| 06/28/2001 | WO2001046226A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046225A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046224A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046222A2 Peptides designed for the diagnosis and treatment of rheumatoid arthritis |
| 06/28/2001 | WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 06/28/2001 | WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | WO2001045750A1 Method for preventing an anaphylactic reaction |
| 06/28/2001 | WO2001045749A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | WO2001045748A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 06/28/2001 | WO2001045746A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | WO2001045742A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 06/28/2001 | WO2001045738A2 Use of heat shock proteins to enhance production of chemokines by a cell |
| 06/28/2001 | WO2001045736A1 Procedure to use staphylococcal bacteria |
| 06/28/2001 | WO2001045735A2 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 06/28/2001 | WO2001045734A1 Chemically-programmable immunity |
| 06/28/2001 | WO2001045730A2 Tweak receptor |
| 06/28/2001 | WO2001045728A2 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 06/28/2001 | WO2001045670A2 A stable immunogenic composition for frozen storage |
| 06/28/2001 | WO2001045669A1 Therapeutic use of particles displaying pathogen-specific binding moieties |
| 06/28/2001 | WO2001045639A2 Methods for protecting against lethal infection with bacillus anthracis |
| 06/28/2001 | WO2001045514A1 Antioxidant compositions extracted from olives and olive by-products |
| 06/28/2001 | WO2001045509A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | WO2001004148A3 Donor strand complemented pilin and adhesin broad-based vaccines |
| 06/28/2001 | WO2000076527A3 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
| 06/28/2001 | WO2000075305A3 Candida albicans genes and proteins coded by said genes |
| 06/28/2001 | WO2000073462A3 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 06/28/2001 | WO2000071725A3 Combination neisserial compositions |
| 06/28/2001 | WO2000071154A3 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000061613A3 Channel forming toxins as antiviral agents |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | WO1997039029A3 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof |
| 06/28/2001 | US20010005910 Coccidiosis vaccines |
| 06/28/2001 | US20010005747 Bispecific molecules comprising a target cell specific ligand and an effector cell specific antibody or functional antibody fragment |
| 06/28/2001 | US20010005717 Gene transfer complexes of a polyethyleneimine having a hydrophilic polymer such as polyoxyethylene glycol coupled thereto, and a nucleic acid; use in gene therapy |
| 06/28/2001 | US20010005507 Predictive test for hepatitis-B resistance |
| 06/28/2001 | DE19962583A1 New antibodies specific for plasma cells, useful for treatment and diagnosis of autoimmune diseases and plasma cell tumors |
| 06/28/2001 | DE19959049A1 Kombination von Verbindungen, welche die biologischen Wirkungen von TNF-alpha und CD95L hemmen Combination of compounds, which inhibit the biological effects of TNF-alpha and CD95L |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | CA2398207A1 Methods for protecting against lethal infection with bacillus anthracis |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395435A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | CA2395429A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 06/28/2001 | CA2395406A1 Method for treating inflammation |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395269A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395208A1 Nucleic acid vaccination |
| 06/28/2001 | CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394741A1 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 06/28/2001 | CA2394015A1 Tweak receptor |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393586A1 Use of heat shock proteins |
| 06/28/2001 | CA2393500A1 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | CA2393018A1 A stable immunogenic composition for frozen storage |
| 06/28/2001 | CA2391374A1 Il-17 homologous polypeptides and therapeutic uses thereof |
| 06/28/2001 | CA2391356A1 Peptides designed for the diagnosis and treatment of rheumatoid arthritis |
| 06/28/2001 | CA2390691A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | CA2384326A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | CA2329676A1 Salmonella vaccine |
| 06/27/2001 | EP1111388A1 Interaction between CD14 and HBV components |
| 06/27/2001 | EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/27/2001 | EP1111053A2 Peptide fragment of the respiratory syncytial virus G protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
| 06/27/2001 | EP1111040A1 Infection of eukaryotic cells with viruses in vitro |
| 06/27/2001 | EP1111039A1 Immature autologous clinical grade dendritic cells intended for vaccination of cancer patients |
| 06/27/2001 | EP1110970A1 Anti-Procalcitonin antibody, their production and use |
| 06/27/2001 | EP1109937A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 06/27/2001 | EP1109921A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
| 06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |